An overview of pneumocystis jirovecii pneumonia for the African generalist practitioner

I. Govender*, O. M. Maphasha, S. Rangiah, C. Steyn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Introduction: Pneumocystis jirovecii is the causative organism of Pneumocystis pneumonia (PCP) in humans, which is more common among immunocompromised patients. Classically patients present with fever, non-productive cough, and dyspnoea. In the HIV-infected individuals the symptoms may be subtle at first, but gradually progress over several weeks. In the HIV-uninfected patient, however, the duration of symptoms is shorter and more severe, mainly due to the increased inflammatory response of the HIV-uninfected patient. Methods: This article focuses on the diagnostic methods and then the management and prophylaxis principles of PCP by reviewing the best current practices and guidelines in Africa. Conclusion: This overview is presented by clinicians who have experience with PCP and is directed mainly at first-line healthcare providers.

Original languageEnglish
Pages (from-to)3200-3207
Number of pages8
JournalAfrican Health Sciences
Issue number4
Publication statusPublished - Dec 2019


  • African generalist practitioner
  • Pneumocystis jirovecii pneumonia


Dive into the research topics of 'An overview of pneumocystis jirovecii pneumonia for the African generalist practitioner'. Together they form a unique fingerprint.

Cite this